| Gretchen Leslie Meyer, FNP | |
|
1 Brian Blvd Ste C, Arden, NC 28704-8485 | |
| (828) 641-0960 | |
| Not Available |
| Full Name | Gretchen Leslie Meyer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 17 Years |
| Location | 1 Brian Blvd Ste C, Arden, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306066576 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 5015660 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Afc Urgent Care And Family Care Of Wnc Pllc | 2567713332 | 49 |
News Archive
Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.
While media attention has been focused recently on coronavirus cases in the Arabian peninsula and the Ebola outbreak in West Africa, experts note that another threat lies in the spread of Chikungunya fever, an illness that is transmitted by mosquitoes and can cause fever, joint and muscle pain, headaches, and rashes. While it does not often cause death, the symptoms can be severe and disabling, with no treatment available.
China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH Probe") from the State Food and Drug Administration of China (the "SFDA").
In an effort to reduce the risks of diabetes and obesity while improving cardiovascular health, Boston Medical Center today announced it has partnered with the YMCA of Greater Boston to form the Exercise and Nutrition to Decrease Diabetes Program.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from an ongoing Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol®), a standard chemotherapy regimen, in patients with metastatic breast cancer.
› Verified 9 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20100202000365 |
News Archive
Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.
While media attention has been focused recently on coronavirus cases in the Arabian peninsula and the Ebola outbreak in West Africa, experts note that another threat lies in the spread of Chikungunya fever, an illness that is transmitted by mosquitoes and can cause fever, joint and muscle pain, headaches, and rashes. While it does not often cause death, the symptoms can be severe and disabling, with no treatment available.
China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH Probe") from the State Food and Drug Administration of China (the "SFDA").
In an effort to reduce the risks of diabetes and obesity while improving cardiovascular health, Boston Medical Center today announced it has partnered with the YMCA of Greater Boston to form the Exercise and Nutrition to Decrease Diabetes Program.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from an ongoing Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol®), a standard chemotherapy regimen, in patients with metastatic breast cancer.
› Verified 9 days ago
| Entity Name | Afc Urgent Care And Family Care Of Wnc Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679066658 PECOS PAC ID: 2567713332 Enrollment ID: O20180919000143 |
News Archive
Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.
While media attention has been focused recently on coronavirus cases in the Arabian peninsula and the Ebola outbreak in West Africa, experts note that another threat lies in the spread of Chikungunya fever, an illness that is transmitted by mosquitoes and can cause fever, joint and muscle pain, headaches, and rashes. While it does not often cause death, the symptoms can be severe and disabling, with no treatment available.
China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH Probe") from the State Food and Drug Administration of China (the "SFDA").
In an effort to reduce the risks of diabetes and obesity while improving cardiovascular health, Boston Medical Center today announced it has partnered with the YMCA of Greater Boston to form the Exercise and Nutrition to Decrease Diabetes Program.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from an ongoing Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol®), a standard chemotherapy regimen, in patients with metastatic breast cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gretchen Leslie Meyer, FNP 1025 Peerless Xing Nw, Cleveland, TN 37312-3764 Ph: (423) 476-5990 | Gretchen Leslie Meyer, FNP 1 Brian Blvd Ste C, Arden, NC 28704-8485 Ph: (828) 641-0960 |
News Archive
Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.
While media attention has been focused recently on coronavirus cases in the Arabian peninsula and the Ebola outbreak in West Africa, experts note that another threat lies in the spread of Chikungunya fever, an illness that is transmitted by mosquitoes and can cause fever, joint and muscle pain, headaches, and rashes. While it does not often cause death, the symptoms can be severe and disabling, with no treatment available.
China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH Probe") from the State Food and Drug Administration of China (the "SFDA").
In an effort to reduce the risks of diabetes and obesity while improving cardiovascular health, Boston Medical Center today announced it has partnered with the YMCA of Greater Boston to form the Exercise and Nutrition to Decrease Diabetes Program.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from an ongoing Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol®), a standard chemotherapy regimen, in patients with metastatic breast cancer.
› Verified 9 days ago
Vanessa Philman, ARNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 436 Airport Rd Ste 20, Arden, NC 28704 Phone: 407-200-2352 | |
Kenneth Walter Sawyer, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 436 Airport Road, Suite 20, Arden, NC 28704 Phone: 407-200-2352 Fax: 407-200-1360 | |
Cherie L Ledford, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15 Skyland Inn Dr, Arden, NC 28704 Phone: 828-654-5005 | |
Mrs. Deborah Whitmire Pittillo, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2695 Hendersonville Rd Ste 200, Arden, NC 28704 Phone: 828-684-6035 Fax: 828-654-8152 | |
Joelle W Falcon, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 310 Long Shoals Rd Ste 310, Arden, NC 28704 Phone: 828-213-8235 | |
Ellen Olson, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Julian Ln Ste 640, Arden, NC 28704 Phone: 828-552-3504 | |
Cynthia A Stephens, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2161 Hendersonville Rd, Arden, NC 28704 Phone: 828-258-8681 Fax: 828-253-4830 |